| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/17/2009 | WO2009112826A1 Furo [3, 2-b] pyrr0l-3-0nes as cathepsin s inhibitors |
| 09/17/2009 | WO2009080227A3 Pyrazole-carboxamide derivatives as p2y12 antagonists |
| 09/17/2009 | WO2009049318A3 Freeze-dried plasma formats for the trauma care field |
| 09/17/2009 | US20090233961 Tartrate derivatives for use as coagulation factor ixa inhibitors |
| 09/17/2009 | US20090233949 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 09/17/2009 | US20090233939 Treatment of amm |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090232902 Nanometer mesoporous silica-based xerogel styptic material and its preparing process and application |
| 09/17/2009 | US20090232876 Method and composition for in situ formation of an artificial blockage to control bleeding |
| 09/17/2009 | US20090232804 Humanized antibodies specific for von willebrand factor |
| 09/17/2009 | US20090232769 Pharmaceutical Composition For Treatment Of Blood Clotting Disorder |
| 09/17/2009 | CA2717497A1 Method for inhibiting the build-up of arterial plaque by administering fullerenes |
| 09/16/2009 | EP2100903A2 Anti-idiotypic antibodies neutralising the inhibiting activity of an inhibiting antibody directed against domain C1 of factor VIII |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2100610A1 Pharmaceutical composition containing low-substituted hydroxypropylcellulose |
| 09/16/2009 | EP2100609A1 Solid medicinal preparation containing mannitol or lactose |
| 09/16/2009 | EP2100608A1 Method for producing solid preparation |
| 09/16/2009 | EP2100607A1 Pharmaceutical composition having improved storage stability |
| 09/16/2009 | EP2100606A1 Film-coated preparation having improved stability |
| 09/16/2009 | EP2099783A1 Bicyclic lactam factor viia inhibitors useful as anticoagulants |
| 09/16/2009 | EP2099775A2 Polymorphic forms of deferasirox (icl670a) |
| 09/16/2009 | EP2099750A1 New crystalline forms |
| 09/16/2009 | EP2099475A1 Subcutaneous administration of coagulation factor viia-related popypeptdes |
| 09/16/2009 | EP2099453A2 Combination therapy of substituted oxazolidinones |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1517919B9 Marked peptides having affinity for a phospholipid and uses |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | CN101534904A Bcl inhibitors treating platelet excess |
| 09/16/2009 | CN101534825A Drug formulation containing fibrate medicament and process for producing the same |
| 09/16/2009 | CN101531723A Method for preparing heparin derivatives by using biological enzyme to selectively modify heparin structure |
| 09/16/2009 | CN101531667A Method for synthesizing prasugrel intermediate and method for synthesizing prasugrel |
| 09/16/2009 | CN101530604A Traditional Chinese medicine composition with effects of nourishing blood and benefiting qi and preparation method thereof |
| 09/16/2009 | CN101530601A Astragalus edge tablets and its quality control method |
| 09/16/2009 | CN101530595A Thrombolysis decoction for treating cardiovascular diseases |
| 09/16/2009 | CN101530574A Traditional Chinese medicine composite capable of treating dysfunctional uterine bleeding |
| 09/16/2009 | CN101530567A Traditional Chinese medicine composition for nourishing blood, tonifying kidney, growing hair and blacking hair and preparation method thereof |
| 09/16/2009 | CN101530561A Hemostyptic medicine |
| 09/16/2009 | CN101530552A Traditional Chinese medicine composition for treating blood deficiency syndrome and preparation method thereof |
| 09/16/2009 | CN101530549A Traditional Chinese medicine composition for invigorating kidney, replenishing essence, benefiting qi and nourishing blood and preparation method thereof |
| 09/16/2009 | CN101530536A Pharmaceutical composition for treating anemia and preparation method thereof |
| 09/16/2009 | CN101530520A Deflocculat suppository powder |
| 09/16/2009 | CN101530501A Traditional Chinese medicine for treating diabetic anemia |
| 09/16/2009 | CN101530478A Chinese medicinal composition with efficacies of preventing myocardial infarct and cerebral infarct, dissolving and eliminating thrombus, activating blood and dissolving stasis, and resisting ageing |
| 09/16/2009 | CN101530465A Total salvianolic acid and Panax notoginsenosides and application of mixture thereof in treatment of septicemia |
| 09/16/2009 | CN101530454A Applications of pterocarpus indicus extract on inhibition of blood platelet aggregation |
| 09/16/2009 | CN101530438A Medicine for treating thrombocytopenic purpura and preparation method thereof |
| 09/16/2009 | CN101530436A Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 09/16/2009 | CN101530430A Nanometer earthworm oral preparation and preparation method thereof |
| 09/16/2009 | CN101530427A Pharmaceutical composition for promoting hematopoiesis and preparation method thereof |
| 09/16/2009 | CN101530409A Thrombi-resistant application of salvianolic acid B |
| 09/16/2009 | CN101530404A Thrombi-resistant application of dihydroxyphenyl lactate |
| 09/16/2009 | CN101530200A Formula of donkey-hide glue combined hearth-care series products and preparation method thereof |
| 09/16/2009 | CN100540559C Lipoid compound regulator and use thereof |
| 09/16/2009 | CN100540523C Novel L-2-(alpha-hydroxy pentyl)benzoate and its preparation method and use |
| 09/16/2009 | CN100540058C Use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 09/15/2009 | US7589178 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2009 | US7589126 Useful as potent and selective activated blood coagulation factor X inhibitors, anticoagulants; for example, ethyl [4-[2-[2-hydroxy-5-(N-hydroxycarbamimidoyl)benzenesulfonyl-amino]ethyl]-2'-methanesulfonylbiphenyl-3-yloxy]acetate; brain and cardiovascular disorders |
| 09/15/2009 | US7589106 Injectable dosage form of aqueous solution including a buffer and optional amino acid at alkaline pH; e.g. argatroban, lactobionic acid, and methionine; free of ethanol, saccharides and sugar alcohols; reducing dosage errors, storage stability |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | CA2434393C Heparin with average molecular mass |
| 09/15/2009 | CA2415752C Novel disaccharides with anti-arthritic action |
| 09/15/2009 | CA2362363C Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 09/15/2009 | CA2342985C Hydroxamate-containing cysteine and serine protease inhibitors |
| 09/15/2009 | CA2309100C Lovastatin compositions derived from red rice fermentation products, fermentation processes and monascus strains therefor |
| 09/15/2009 | CA2148871C Method of preventing hyperproliferative vascular disease |
| 09/11/2009 | WO2009110495A1 Promoter for secretion of insulin-like growth factor-1, and food or beverage containing the same |
| 09/11/2009 | WO2009109741A1 Clopidogrel solution for oral administration |
| 09/11/2009 | WO2009061889A4 Grape polyphenolics for platelet and bacterial control |
| 09/11/2009 | WO2009042962A9 Antidotes for factor xa inhibitors and methods of using the same |
| 09/10/2009 | US20090227976 Multiple biocompatible polymeric strand aneurysm embolization system and method |
| 09/10/2009 | US20090227809 New 2-(alpha-hydroxypentyl) benzoates, their preparations and their uses |
| 09/10/2009 | US20090227565 Biphenyl Vasopressin Agonists |
| 09/10/2009 | US20090227530 Sodium channel blockers |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227508 Peptides that bind to the erythropoietin receptor |
| 09/10/2009 | US20090227504 Pegylated Factor VII Glycoforms |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090227496 Method of Producing Recombinant TAT-HOXB4H Protein for Use as a Stimulant of Hematopoiesis In Vivo |
| 09/10/2009 | US20090227495 Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof |
| 09/10/2009 | US20090227030 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/10/2009 | US20090227002 Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs |
| 09/10/2009 | US20090226987 Desaturase Genes, Enzymes Encoded Thereby, and Uses Thereof |
| 09/10/2009 | US20090226526 Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same |
| 09/10/2009 | US20090226515 Statin compositions |
| 09/10/2009 | US20090226422 Chemical Inhibitors of Inhibitors of Differentiation |
| 09/10/2009 | US20090226415 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 09/10/2009 | US20090226413 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/10/2009 | US20090226412 Agent for reduction of bleeding in cerebrovascular disorder |
| 09/10/2009 | US20090226410 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/09/2009 | EP2098230A1 Use of cytoskeletal inhibitors in crystalline form for the inhibition or prevention of restenosis |
| 09/09/2009 | EP2097403A2 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate |
| 09/09/2009 | EP2097390A1 Amino quinazolines derivatives wuth blood platelet reducing properties |
| 09/09/2009 | EP2097108A2 Factor ix moiety-polymer conjugates having a releaseable linkage |
| 09/09/2009 | EP1517918B9 Peptides having affinity for a phospholipid and uses |
| 09/09/2009 | EP1515947B1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 09/09/2009 | EP1397355B1 Pyridyl cyanoguanidine compounds |
| 09/09/2009 | EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 09/09/2009 | CN101525611A Fusarium plasmin and preparation method thereof |
| 09/09/2009 | CN101525598A Method for purifying human urinary trypsin inhibitor |